Our Program

lab
The program designed by a renowned team of dedicated scientist and physicians, lead by our founder Dr. Casey Nabavi, exclusively for Cellulogix International is the only commercial provider of therapeutic adult stem cell and human cord blood applications operating from the United States.

Patients are asked to complete an application form. You may apply online or contact our office and request one be sent to you. Upon receipt of the completed application form, one of our staff members will contact the patient to set up an appointment for a phone consultation with one of our trusted physicians. The consultation is free and there are no obligations.

Our program consists of three major components:

1 – Patient Specific Treatment Protocols

Each patient is evaluated and a specific protocol is designed. The patient specific protocol will determine:
• Type of cells needed
• The number of each cell lines needed
• The manner of administration of the cells

2 – Differentiated Stem Cell Lines

The stem cells are then tested, purified and differentiated into the necessary cell lines at our laboratory.
*Cellulogix International adheres to all regulations that have been set by the Good Laboratory Practices (GLP).*

3 – Treatments

Cellulogix International is working to establish a worldwide network of clinical facilities. With clinics currently located in North America, in Tampa, Florida and Zona Rio, Mexico, as well as in Central America in Guatemala City, Guatemala.

Most procedures are non-invasive and are performed on an out-patient basis.Some procedures require patients to stay overnight. In all cases ground transportation and accommodations are pre-arranged by our staff.

Industry News

Stanford University Awarded over $5M for Research

Stanford University Medical Center. Four researchers at the Stanford University School of Medicine have been awarded just over $5.5 million for their stem cell research projects.
The California Institute for Regenerative Medicine is now funding projects that are attempting to find ways to overcome immune system rejection of transplanted stem cells. The institute is the state [...]

Read More

Patient Shares Comments Re: His Progress Since Treatment for Ataxia

Dear Cellulogix:   I’m Phil D. and I had my transplant the week of May 5th 2009.  We have communicated several times in the past but not lately. I had my 13th month post transplant exam with my Neurologist yesterday June 18th and thought Dr.Nabavi and you would be interested in an update on my condition. [...]

Read More

New Stem Cell Center At UC Irvine

Hub of hope and healing
Dedication of UCI’s Gross Hall is milestone in effort to unlock stem cells’ potential
 Daniel A. Anderson / University Communications
The May 14 dedication of UCI’s Sue & Bill Gross Hall: A CIRM Institute was a milestone in the effort to unlock stem cells’ potential. Here, CIRM fellows are briefed before leading guest [...]

Read More

Need to Send Medical Records?

Cellulogix recently added the Doc’s@cellulogix email address for our patients to send in their medical reports and all other pertinent information that may be requested. This is helpful if you want our team of specialists to have your medical information prior to your initial consultation as well as follow up reports that are requested.

Read More